TacticScaleWhat Privia Health Does & How It Makes Money (PRVA)
Updated October 2026 · reflects Privia Health's latest reported financials
Physician-enablement company helping doctors run practices and succeed in value-based care. Privia earns revenue by providing management services and technology to affiliated physician practices and by negotiating payer contracts through its single-TIN medical group, including shared financial incentives from value-based care arrangements run through its accountable care organizations.
How Privia Health makes money
Privia earns revenue by providing management services and technology to affiliated physician practices and by negotiating payer contracts through its single-TIN medical group, including shared financial incentives from value-based care arrangements run through its accountable care organizations.
What Privia Health does
Privia Health Group is a national physician-enablement company founded in 2007 and headquartered in Arlington, Virginia. It works with physician practices, health plans, and health systems, offering a management services organization that reduces administrative burden and technology and population health tools that streamline providers' workflows. Privia also operates a single-TIN medical group that gives affiliated doctors collective negotiating power, clinical integration, and aligned financial incentives, along with accountable care organizations that aim to engage patients, reduce inappropriate utilization, and improve quality metrics under value-based care. A network for purchasers and payers connects providers across its platform to better coordinate each patient's care.
Products & services
- Physician technology and population health tools
- Management services organization (MSO)
- Single-TIN medical group
- Accountable care organization (ACO)
- Network for purchasers and payers
What is Privia Health worth?
On an owner-earnings DCF, Privia Health's most-likely value is about $47 versus a recent price near $21 (127% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$13) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Doximity (DOCS) · IQVIA (IQV) · CVS Health (CVS) · Astrana Health (ASTH) · Pediatrix Medical (MD)